Letters after your name
Clinical Trials Assistant
- Additional job titles
Dr Katja Pfafferott has joined the Oxford Vaccine Group as a Clinical Trial Assistant in August 2015 after having spent the last 10 years as Post-doctoral researcher in Clinical Medicine in various laboratories around the globe. The desire for a change in career has prompted her move into Trial administration and she is currently involved in the planning, organisation and administration of several Trials.
The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
von Delft A. et al, (2016), Gut, 65, 112 - 123
Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.
Yue L. et al, (2015), PLoS Pathog, 11
Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.
Pfafferott K. et al, (2015), PLoS One, 10
Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Fenton-May AE. et al, (2013), Retrovirology, 10
Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencing.
Li H. et al, (2013), J Infect Dis, 208, 1598 - 1603